Adnane Louridi
Known title: Chief Accounting OfficerCIK: 0002128890
Associated companies
Transaction History
| BCO | ▲ Buy | Grant | 1,420 | $0 | 5/1/2026 | View on chart |
| BCO | ▲ Buy | Grant | 5,186 | $0 | 5/1/2026 | View on chart |
| BCO | ▲ Buy | Grant | 1,420 | $0 | 5/1/2026 | View on chart |
| BCO | ▲ Buy | Grant | 5,186 | $0 | 5/1/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Brink's Gets CMA Approval for NCR Atleos Deal Remedy
Brink's received acceptance in principle from the UK's CMA regarding a proposed remedy for its pending acquisition of NCR Atleos. The company also reported Q2 2026 results and confirmed that a potential sale of UK assets will not impact expected $200M in annual synergies. This regulatory progress is a key step in finalizing the transaction.
Brink's Gets CMA Approval for NCR Atleos Deal Remedy. Brink's received acceptance in principle from the UK's CMA regarding a proposed remedy for its pending acquisition of NCR Atleos. The company also reported Q2 2026 results and confirmed that a potential sale of UK assets will not impact expected $200M in annual synergies. This regulatory progress is a key step in finalizing the transaction.